Rohto Pharmaceutical Co.,Ltd (TYO:4527) will acquire a 51% stake in Thailand-based wellness company Thann Oryza Co., Ltd. through a subsidiary, aiming to expand its presence in the Asia-originated holistic wellness sector, according to a Wednesday filing on the Tokyo Stock Exchange.
The acquisition is expected to close on March 31. Financial terms of the deal were not disclosed due to confidentiality agreements.
Thann, founded in 2003 in Bangkok, operates retail stores, spa facilities, and wellness services across Asia, including Thailand, China, Hong Kong, Japan, and Mongolia, and distributes products in 14 countries. The brand is known for its plant-based skincare products and aromatherapy-focused offerings.